From Epidemics to Pandemics: Over a Decade of Strengthening SARInet Laboratory Surveillance and Response for Respiratory Viruses in the Americas - Scorecard - MDSpire

From Epidemics to Pandemics: Over a Decade of Strengthening SARInet Laboratory Surveillance and Response for Respiratory Viruses in the Americas

  • By

  • Juliana Almeida Leite

  • Priscila S Born

  • Ángel Rodríguez

  • Paula Couto

  • Mauricio Cerpa

  • Jean-Marc Gabastou

  • Lionel Gresh

  • Leticia Franco

  • Mariela G Martínez

  • Madelaine Sugasti

  • Jorge H Jara

  • Lidia Rodondo-Bravo

  • Iyanna Wellington Perkins

  • Andrea Patricia Villalobos Rodríguez

  • Rosa Ramirez

  • Ximena Terrazas

  • Juliana Barbosa

  • Marc Rondy

  • Andrea S Vicari

  • Sylvain Aldighieri

  • Richard Webby

  • Wenqing Zhang

  • Dimitry Pereyaslov

  • Magdi Samaan

  • Jairo Méndez-Rico

  • SARInet plus laboratory network

  • Jairo Méndez-Rico

  • Juliana Almeida Leite

  • Priscila S Born

  • Andrea Vicari

  • Elsa Baumeister

  • Andrea Pontoriero

  • Alicia Camara

  • Andrea Lerman

  • Osvaldo Uez

  • Indira Martin

  • Draven Johnson

  • Songee Beckles

  • Kasandra Forde

  • Aldo Sosa

  • Ruby Aguillon

  • Roxana Loayza

  • Cinthia Avila

  • Marilda Mendonça Siqueira

  • Fernando Couto Motta

  • Paola Cristina Resende

  • Luana Soares Barbagelata

  • Terezinha Maria de Paiva

  • SueMin Nathaniel

  • Risha Singh

  • Rodrigo Fasce

  • Patricia Bustos

  • Sergio Yebrail Gomez Rangel

  • Paula Estefania Rodriguez Romero

  • Hebleen Brenes

  • Jorge Sequeira-Soto

  • María Guadalupe Guzmán

  • Elias Guilarte Garcia

  • Catherina Jemmott

  • Eric Carbon

  • Lucía de la Cruz

  • Nurys de Castro

  • Alfredo Bruno

  • Doménica de Mora Coloma

  • Dalia Xochitl Sandoval López

  • Denis Gerson Jovel Alvarado

  • Selene González

  • Christa Leal

  • Joyce Whyte-Chin

  • Mustapha Abdul-Kadir

  • Jacques Boncy

  • Ito Journel

  • Mitzi Castro Paz

  • Dulce María Durón

  • Michelle Brown

  • Suwanie Lewis

  • Irma Lopez Martinez

  • Gisela Barrera-Badillo

  • Brechla Moreno

  • Danilo Franco

  • Cynthia Vazquez

  • María José Ortega

  • Johanna Balbuena-Torres

  • Maribel Huaringa

  • Candace Gumbs

  • Andrea Williams

  • Joseph N France

  • Wayne Felicien

  • Vernel Feloion

  • Phyllis S Pinas

  • Merissa A Garraway-Miller

  • Arlene Siebs

  • Hector Chiparelli

  • Natalia Goñi

  • Lieska Rodriguez

  • Pierina D’Angelo

  • March 10, 2025

  • 0 min

Share

Clinical Scorecard: Evolving from Epidemics to Pandemics: A Decade of Enhancing SARInet's Laboratory Surveillance and Response for Respiratory Viruses Across the Americas

At a Glance

CategoryDetail
ConditionEmerging and reemerging respiratory viruses with epidemic and pandemic potential, including influenza and SARS-CoV-2
Key MechanismsLaboratory surveillance, genomic characterization, data sharing via FluNet and PAHOFlu, and regional network coordination through SARInet and WHO e-GISRS
Target PopulationPopulations across the Americas region vulnerable to respiratory virus epidemics and pandemics
Care SettingPublic health laboratories, sentinel hospitals, and national reference laboratories within the Americas

Key Highlights

  • SARInet, established in 2014, expanded laboratory surveillance capacity for respiratory viruses in 31 countries across the Americas.
  • Integration of surveillance for influenza, SARS-CoV-2, and other respiratory viruses under SARInet plus enhances epidemic and pandemic preparedness.
  • PAHO and WHO collaborations support training, logistics, and data systems (FluNet, PAHOFlu) to improve timely and accurate respiratory virus surveillance.

Guideline-Based Recommendations

Diagnosis

  • Use high-quality standardized real-time RT-PCR assays for rapid and accurate detection of respiratory viruses.
  • Conduct antigenic and genetic characterization of detected viruses to inform vaccine composition and public health response.

Management

  • Strengthen laboratory capacity and regional networks to enable early detection and response to emerging respiratory virus threats.
  • Implement integrated information systems (e.g., PAHOFlu) for real-time monitoring and data sharing among health authorities.

Monitoring & Follow-up

  • Regularly report virologic data through FluNet to support global surveillance efforts.
  • Participate in WHO External Quality Assurance Programs to ensure laboratory testing accuracy and reliability.

Risks

  • Challenges include lack of trained personnel, logistical issues in sample transportation, and communication gaps between laboratories and epidemiology teams.
  • Inconsistent data submission may disrupt timely detection and response to respiratory virus outbreaks.

Patient & Prescribing Data

Populations affected by respiratory virus epidemics and pandemics in the Americas

Not applicable; article focuses on surveillance and laboratory response rather than clinical treatment or prescribing.

Clinical Best Practices

  • Develop and maintain robust laboratory networks such as SARInet to support respiratory virus surveillance.
  • Enhance laboratory capacity through training, logistics support, and adoption of molecular diagnostic techniques.
  • Foster collaboration between laboratories, epidemiology teams, and public health authorities for integrated surveillance and response.
  • Utilize global platforms like FluNet and PAHOFlu for data sharing and real-time monitoring.
  • Ensure participation in quality assurance programs to maintain high standards in laboratory testing.

References

Original Source(s)

Related Content